Scopus BioPharma
Pre-clinicalWe develop transformational therapeutics targeting serious diseases. Our lead program is a targeted immuno-oncology gene therapy for the treatment of multiple cancers.
Founded
2016
Focus
RNA & Gene Therapy
About
We develop transformational therapeutics targeting serious diseases. Our lead program is a targeted immuno-oncology gene therapy for the treatment of multiple cancers.
Funding History
2Total raised: $45M
Series B$30MUndisclosedNov 15, 2021
Series A$15MUndisclosedMay 15, 2019
Company Info
TypePrivate
Founded2016
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile